NIH delivered new COVID-19 testing technologies to meet US demand
On Jul. 31, 2020, the National Institutes of Health (NIH) announced that it had invested $248.7 million in…
On Jul. 31, 2020, the National Institutes of Health (NIH) announced that it had invested $248.7 million in…
On Jul. 29, 2020, PharmaCyte Biotech announced that the COVID-19 Molecular tests it has licensed from Hai Kang…
On Jul. 18, 2020, the U.S. Food and Drug Administration (FDA) reissued an emergency use authorization (EUA) to…
On Jul. 1, 2020, OPKO Health announced the results of COVID-19 molecular PCR and antibody tests for nursing…
On Jun. 8, 2020, OraSure Technologies announced that Phosphorus Diagnostics, a leader in diagnostic and bioinformatic solutions for…
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
On May 14, 2020 Abivax announced that ABX464 inhibited replication of SARS-CoV-2 in an in vitro reconstituted human…
On May 12, 2020, Thermo Fisher Scientific announced the FDA has further expanded emergency use authorization (EUA) for…
On May 11, 2020, Todos Medical announced an exclusive distribution agreement with Gnomegen for the distribution of its…
On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…
On May 6, 2020, PharmaCyte Biotech announced it had received Medical Devices Establishment Registration with the U.S. Food and…
On May 6, 2020, Meridian Bioscience announced a collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for…
On May 5, 2020, IGEA Pharma announced that an evaluation by the University of Miami Miller School of…
On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…
On Apr. 30, 2020, Medigen Vaccine Biologics (MVB) complied with EU CE requirements, completed the EU declaration of…
On Apr. 30, 2020, Medigen Vaccine Biologics (MVC) announced its SARS-CoV-2 qPCR Kit complied with EU CE requirements,…
On Apr. 27, 2020, Meridian Bioscience announced the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step…
On Apr. 25, 2020, the World Health Organization (WHO) reported there was currently ‘no evidence’ that people who…
On Apr. 21, 2020, Todos Medical announced that Gnomegen has received Emergency Use Authorization from the FDA for…
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
On Apr. 15, 2020, Todos Medical announced the U.S. Food and Drug Administration (FDA) has accepted Todos Medical’s application…
On Apr. 8, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for…
On Mar. 26, 2020, Thermo Fisher Scientific announced it had received the CE mark in the European Union…
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
On Mar. 13, 2020, IDEXX Laboratories announced the company had seen no positive results in pets to date…
On Mar. 13, 2020, Luminex announced that four independent clinical laboratories had validated laboratory developed tests (LDTs) for…